ARTICLE | Clinical News
GeneOne, Inovio preclinical data
February 22, 2016 8:00 AM UTC
Inovio said its SynCon Zika DNA vaccine led to seroconversion in all vaccinated mice and generated “robust and broad” T cell responses. The company now plans to evaluate the vaccine in non-human prima...